Wolters Kluwer agrees to acquire AgileMD for up to $100 million
Wolters Kluwer Health has signed an agreement to acquire AgileMD in a deal valued at up to $100 million. The transaction is expected to close in the first quarter of 2027 or sooner, subject to customary closing conditions and governmental approvals.
Key takeaways · 4
- 01
Treat the acquisition as pending: it had not closed when the report was published.
- 02
The proposed price is up to $100 million, including $40 million upfront.
- 03
Pathways brings health systems’ local guidelines into electronic health record workflows.
- 04
Wolters Kluwer says it plans to extend UpToDate into embedded workflows, local guidelines and new digital health applications.
Deal terms and timing
Wolters Kluwer Health announced that it had signed an agreement to acquire AgileMD on November 13, 2026.[1] The proposed acquisition is valued at up to $100 million, including $40 million upfront; the deferred balance is contingent on performance targets.[1] The transaction is expected to close in the first quarter of 2027 or sooner, subject to customary closing conditions and governmental approvals.[1] It had not closed when the report was published.[1] All 23 AgileMD employees are expected to join Wolters Kluwer Health.[1]
Products for clinical workflows
AgileMD’s Pathways product brings a health system’s local guidelines into electronic health record workflows.[1] Clinicians can use it to enter orders, align order sets and decision support, generate documentation, and incorporate laboratory results and vital signs.[1] The product also supports measuring outcomes and reviewing protocol delivery in the same work environment.[1] AgileMD’s eCART is a real-time AI surveillance engine that identifies and prioritizes patients at risk of all-cause clinical deterioration.[1] Wolters Kluwer says eCART is designed to help care teams escalate treatment and reduce mortality rates.[1]
Reported validation and reach
AgileMD says eCART’s analytic was trained and tested on nearly 3 million patient encounters from 28 hospitals across six health systems.[1] Retrospective and prospective validation covered sepsis, COPD, CHF and COVID populations.[1] AgileMD reports that its platform has reached more than 400 hospitals, 150,000 clinical users and 4.425 million patient encounters.[1] The company also reports more than 4,800 live pathways at partner institutions, spanning adult, pediatric and neonatal care and multiple clinical settings.[1]
Strategy and financial expectations
Wolters Kluwer intends to combine AgileMD with UpToDate Expert AI and its partnerships to extend UpToDate into embedded workflows, local guidelines and new digital health applications.[1] Wolters Kluwer says UpToDate Expert AI, introduced in September 2025, has been adopted by more than 2,700 U.S. hospitals and health systems, representing more than 95% of its U.S.-based UpToDate Enterprise Edition customers.[1] Wolters Kluwer projects AgileMD will reach $7 million in annual recurring revenue by the end of 2026.[1] It expects the acquisition to have an immaterial effect on adjusted earnings and to achieve a return on invested capital at or above its 8% after-tax weighted average cost of capital within three to five years.[1]
Wolters Kluwer intends to combine AgileMD with UpToDate Expert AI and its partnerships to extend UpToDate into embedded workflows, local guidelines and new digital health applications. For professionals evaluating clinical tools, the announced product scope and the still-pending transaction are important distinctions when considering future integration plans.
Why it matters
AI training for your team
kju.ai is built for teams: daily sessions, team analytics, and rollout support for your organization.
How this developed
14 November 2026
Wolters Kluwer agrees to acquire AgileMD for up to $100 million
Sources
- Wolters Kluwer Agrees to Buy Clinical AI Company AgileMD – Unite.AIunite.ai
- Newsagilemd.com
